Since high levels of AhR, CYP1A1, and CYP1B1 genes are correlated with impaired folliculogenesis, the inhibition of AhR signaling pathway might be considered as a novel treatment approach for PCOS patients [42]. This evidence concerns the gene CYP1B1 and polycystic ovary syndrome.